Clinical variables | Postoperative BG level (mmol/L) | ||||
---|---|---|---|---|---|
Quartile 1 (n = 348) | Quartile 2 (n = 354) | Quartile 3 (n = 341) | Quartile 4 (n = 352) | P | |
Age (year) | 56.3 ± 5.7 | 57.2 ± 5.5 | 57.5 ± 5.7 | 58.0 ± 5.5 | 0.001 |
Males, n (%) | 138 (39.7) | 117 (33.1) | 108 (31.7) | 96 (27.3) | 0.006 |
Smoking, n (%) | 37 (10.6) | 42 (11.9) | 30 (8.8) | 36 (10.2) | 0.618 |
Hypertension, n (%) | 29 (8.3%) | 30 (8.5) | 39 (11.4) | 40 (11.4) | 0.319 |
NYHA III-IV, n (%) | 148 (42.5) | 129 (36.4) | 162 (47.5) | 164 (46.6) | 0.012 |
FBG (mmol/L) | 4.7 ± 0.5 | 4.8 ± 0.6 | 4.9 ± 0.6 | 4.9 ± 0.6 | <0.001 |
Postoperative glucose (mmol/L) | 8.1 ± 1.0 | 10.1 ± 0.5 | 12.0 ± 0.7 | 15.8 ± 2.0 | <0.001 |
Serum creatinine (umol/L) | 83.4 ± 29.7 | 78.6 ± 22.3 | 79.6 ± 24.6 | 81.5 ± 25.7 | 0.069 |
lgCRP (mg/L) | 0.5 ± 0.4 | 0.5 ± 0.4 | 0.5 ± 0.4 | 0.6 ± 0.4 | 0.006 |
Glycated hemoglobin (%) | 5.8 ± 0.4 | 5.8 ± 0.4 | 5.8 ± 0.4 | 5.8 ± 0.4 | 0.222 |
LVEF (%) | 61.7 ± 8.6 | 62.1 ± 8.6 | 62.5 ± 8.5 | 60.7 ± 10.3 | 0.047 |
Type of surgery | |||||
Aortic valve replacement | 170 (48.9) | 163 (46.0) | 189 (55.4) | 198 (56.3) | 0.015 |
Mitral valve replacement | 331 (95.1) | 318 (95.5) | 314 (92.1) | 326 (92.6) | 0.174 |
Tricuspid intervention | 270 (77.6) | 275 (77.7) | 254 (74.5) | 271 (77.0) | 0.730 |
CABG | 13 (3.7) | 12 (3.4) | 14 (4.1) | 20 (5.7) | 0.445 |
In-hospital death | 4 (1.1) | 8 (2.3) | 6 (1.8) | 29 (8.2) | <0.001 |
In-hospital MACEs | 7 (2.0) | 11 (3.1) | 9 (2.6) | 34 (9.7) | <0.001 |